DEVELOPING: Why the medical community is thrilled by U.S. support for a 'breakthrough' HIV drug

BREAKING NEWS UPDATE Goats and Soda Why the medical community is thrilled by U.S. support for a 'breakthrough' HIV drug September 4, 20253:35 PM ET By Gabrielle Emanuel A vial of lenacapavir, the new HIV prevention injectable drug that only needs to be administered twice yearly but provides almost complete protection. KEY DETAILS: • Nardus EngelbrechtAP hide caption toggle caption Nardus EngelbrechtAP The U.S. • announced Thursday that it will make an investment in the new HIV prevention drug called lenacapavir that's been hailed as a "breakthrough" and a "game changer" by the medical community. • The Department of State says the aim is to reach up to 2 million people by 2028 with the antiretroviral medication that has the potential to save hundreds of thousands of lives. This is a developing story. More details will be provided as they become available. *Source: Npr*